🇺🇸 FDA
Company

RedHill

RedHill Biopharma

RDHL biotech USA

Quick answer

RedHill is a biotech company (RDHL) headquartered in TEL AVIV, L3, USA with 14 tracked pipeline programs.

Pipeline (14)

project

Opaganib

COVID-19

Phase 3 · small_molecule · terminated

2 trials project

Part A: Upamostat 200 mg

Covid19

Phase 3 · small_molecule · terminated

1 trials project

RHB-102

Gastroenteritis

Phase 3 · small_molecule · completed

1 trials project

RHB-104

Crohn's Disease

Phase 3 · small_molecule · completed

1 trials project

RHB-104 (fixed-dose combination: 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine)

Crohn Disease

Phase 3 · small_molecule · completed

1 trials project

RHB-105

Helicobacter Pylori Infection

Phase 3 · small_molecule · completed

1 trials project

RHB-105

Dyspepsia

Phase 3 · small_molecule · completed

1 trials project

RHB-204

Pulmonary Mycobacterium Avium Complex Infection

Phase 3 · small_molecule · terminated

1 trials project

ABC294640

Cholangiocarcinoma

Phase 2 · small_molecule · completed

1 trials project

BEKINDA

Irritable Bowel Syndrome With Diarrhea

Phase 2 · small_molecule · completed

1 trials project

Opaganib

Coronavirus Infections

Phase 2 · small_molecule · completed

1 trials project

RHB-104

Relapsing Remitting Multiple Sclerosis

Phase 2 · small_molecule · completed

1 trials project

Rifamycin SV-MMX

Traveler's Diarrhea

Phase 2 · small_molecule · active

2 trials project

Upamostat

SARS-CoV-2

Phase 2 · small_molecule · completed

1 trials

Patents (8)

patent

US 12370206

Therapy for inhibition of single-stranded RNA virus replication

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12115150

Biomarkers of coronavirus pneumonia

Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11931463

All-in-one fixed-dose combination for treating Helicobacter pylori infection

Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11918560

Serine protease inhibitor for treating coronavirus infection

Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11878011

Method for eradicating Helicobacter pylori infection in patients regardless of b

Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11786541

Inhibitor of sphingosine kinase 2 for treating Ebola

Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11633385

Combination compositions for treatment of cancer

Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11590154

Triple antibiotic fixed-dose combination products, dosing regimen, methods, and

Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)